Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection

Recruiting now

Conditions studied: Dengue, Dengue Fever, Dengue Fever With Warning Signs

In brief

This 3-year prospective observational study aims to identify clinical and laboratory risk factors associated with hospitalization in patients with confirmed dengue virus infection. It also seeks to analyze real-world transfusion practices and their outcomes. The study will be conducted in a second-level hospital in northern Mexico and will follow patients from emergency department entry to clinical resolution or hospital discharge.

Key facts

Study ID

NCT07007585

Run by

Jose Ivan Rodriguez de Molina Serrano

People needed

100

Starts

2025-08-01

Expected to finish

2028-08-30

Last updated by the study team

2025-09-16

Who can join

Age: 5 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged ≥5 years
• Laboratory-confirmed dengue infection (NS1, IgM, or PCR)
• First contact at emergency or outpatient services
• Informed consent signed by the patient or legal guardian

You may not qualify if…

• Co-infection with other arboviruses or COVID-19
• Pre-existing hematologic or oncologic disease
• Refusal to sign informed consent

Where it is running

• Clinica Mexico — Piedras Negras, Coahuila, Mexico (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.